Pharmacist, Research Disease Group

Job Details

Job Ref:
42933

Location:
450 Brookline Ave, Boston, MA 02215

Category:
Pharmacy

Employment Type:
Full time

Work Location:
Hybrid: 2-3 days onsite/week

Overview

The Research Disease Group Pharmacist II supports patient care research by reviewing protocol proposals, coordinating protocol education, coordinating study drug supplies, and assisting investigators with protocol development and implementation.

This position’s work location is partial remote with two or three days per week remote. The selected candidate may only work remote days from a New England state (ME, VT, NH, MA, CT, RI).  

Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals. 

Click here to see a video of a "Day in the life of a Pharmacist at Dana-Farber".  

Responsibilities

  • Complete timely and accurate pharmacy reviews of new or amended Clinical Research Protocol documentation throughout the activation process; work toward an understanding of daily/weekly workload and timelines.
  • Represent the pharmacy department on key clinical research review committees for required activation signoff and ensure compliance with DF/HCC standard operating procedures.
  • Collaborate with multidisciplinary clinical teams, study teams, industry sponsors and other departments internal and external to the Institute, communicate logistics and provides education on research details and operational considerations involved with the clinical research program.
  • Work collaboratively with Research Operations regarding investigational drug supply/inventory, and drug ordering as well as troubleshoot active patient issues.
  • Follow progress of the clinical research protocol along with the study team for safety, efficacy, appropriateness of drug and dose and/or operational concerns.
  • Create and validate investigational medication entries and validate beacon ordering templates for DF/HCC sites.
  • Participate in audits (e.g., preparation activities, NCI, sponsor quality assurance, FDA, etc.).
  • Participate in draft reviews of clinical research trials.
  • Participate in new staff training/orientation and serve as a resource to Pharmacist I, Research Disease Group.
  • Other duties and projects as assigned.

Qualifications

The Research Disease Group Pharmacist II must meet the following requirements to be hired and maintain their position in the Pharmacy Department at DFCI.

 

Minimum Education:
All Pharmacists require a Bachelor of Science in Pharmacy or Doctor of Pharmacy degree from an accredited college of Pharmacy.  

Minimum Experience:
3 years of hospital pharmacy or pharmaceutical industry experience with at least 2 years of oncology, regulatory, or clinical research experience required.

License/Certification/Registration:
Must be licensed to practice pharmacy in the Commonwealth of Massachusetts.

KNOWLEDGE, SKILLS, AND ABILITIES REQUIRED:

  • Ability to critically assess a clinical document, references and/or drug information sources with attention to detail.
  • Good organizational and time management skills, with an ability to prioritize multiple projects and assignments.
  • Detail oriented with good written and verbal communication skills.
  • Works effectively as a member of a unit team, cross functional teams and thrives in team-oriented environments.
  • Prioritizes and adapts to change; accepts additional responsibilities based on the changing needs of the work setting.

At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply. 

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.

EEOC Poster 

Follow Dana-Farber on Social Media
  • Coping with Metastatic Breast Cancer: Improving Quality of Life at MBC Patient Forum 2019

  • Gels and polishes used in #manicures aren’t cancer-causing. But there is concern that some devices that use ultraviolet light to help polishes and gels dry faster could pose a small risk for #skincancer.

  • Tom McLaughlin would have rather spent his holiday week at home with his extended family, but under the circumstances the 76-year-old grandfather said he was very happy where he was — and still had much to be thankful for. http://ms.spr.ly/6185ZcAML

  • Lynch syndrome is a common and often under-diagnosed inherited condition that increases one's risk for a variety of cancers, including colon, rectal, uterine, ovarian, urinary tract, and other malignancies.

  • Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. http://ms.spr.ly/6186eW78u

  • When Chuck Stravin was diagnosed with renal cell carcinoma in 2015, one of his biggest fears was not living long enough to see his four young daughters get married. The disease later metastasized to his lungs as stage IV cancer, but thanks to groundbreaking clinical trials and a care team he considers family, Stravin is checking important items off his bucket list.

    On Dec. 30, Stravin took a break from ongoing treatment to walk his daughter Kayla down the aisle at her wedding. Several members of his care team at Dana-Farber Brigham Cancer Center including oncologist Toni Choueiri, MD, attended the ceremony, and photos that Chuck tweeted of him and Kayla from that day — accompanied by words of thanks to Choueiri and Co. for making it happen — quickly went viral. http://ms.spr.ly/6184g146C

  • Butternut Squash Mac and Cheese Recipe: For your homemade mac and cheese, take out the typical roux (butter, milk, flour) and replace it with pureed butternut squash. You’ll have a lower calorie meal, without losing the lusciousness of this classic rich dish. And there’s a bonus: you’ll be adding phytonutrients, vitamins, minerals and fiber.

  • Blum Spotlight on Dana-Farber Resources: SoulMates

  • Load More